GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Microbio Co Ltd (ROCO:4128) » Definitions » Earnings per Share (Diluted)

Microbio Co (ROCO:4128) Earnings per Share (Diluted) : NT$-1.88 (TTM As of Mar. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Microbio Co Earnings per Share (Diluted)?

Microbio Co's Earnings per Share (Diluted) for the three months ended in Mar. 2025 was NT$-0.42. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-1.88.

Microbio Co's EPS (Basic) for the three months ended in Mar. 2025 was NT$-0.42. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-1.88.

Microbio Co's EPS without NRI for the three months ended in Mar. 2025 was NT$-0.42. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-1.88.

During the past 13 years, Microbio Co's highest 3-Year average EPS without NRI Growth Rate was 34.30% per year. The lowest was -52.20% per year. And the median was 3.30% per year.


Microbio Co Earnings per Share (Diluted) Historical Data

The historical data trend for Microbio Co's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbio Co Earnings per Share (Diluted) Chart

Microbio Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Earnings per Share (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.21 0.09 0.36 -2.01 -1.87

Microbio Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Earnings per Share (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.41 -0.26 -0.67 -0.53 -0.42

Competitive Comparison of Microbio Co's Earnings per Share (Diluted)

For the Packaged Foods subindustry, Microbio Co's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Microbio Co's PE Ratio Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Microbio Co's PE Ratio distribution charts can be found below:

* The bar in red indicates where Microbio Co's PE Ratio falls into.


;
;

Microbio Co Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Microbio Co's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2024 is calculated as

Diluted Earnings Per Share (A: Dec. 2024 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1100.803-0)/588.170
=-1.87

Microbio Co's Earnings Per Share (Diluted) for the quarter that ended in Mar. 2025 is calculated as

Diluted Earnings Per Share (Q: Mar. 2025 )=(Net Income - Preferred Dividends / Shares Outstanding (Diluted Average)
=(-249.441-0)/593.907
=-0.42

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-1.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.


Microbio Co  (ROCO:4128) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Microbio Co Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Microbio Co's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Microbio Co Business Description

Traded in Other Exchanges
N/A
Address
Yuan Qu Street, No.3, 14th Floor, Sanchongli, Nangang District, Taipei, TWN, 115
Microbio Co Ltd is engaged in the research and development, manufacturing, and trading of biotech drugs and dietary supplements. Its drug portfolio includes MS-20, a mixture of soybean fermentation metabolites, which improves fatigue and loss of appetite in cancer patients undergoing chemotherapy. In addition, the company also offers Lee Herb series of herbal essence drinks, Tien Chun Bao oral solutions, Herbiron oral solutions for iron deficiency, and other pharmaceutical and organic products. The company generates revenue from biotech drug research and development, and the sale of dietary supplements. A majority of its revenue is generated from the sale of its dietary supplements.

Microbio Co Headlines

No Headlines